Balyasny Asset Management LLC Spring Works Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $1.09 Million - $1.48 Million	47,218 New	47,218 $1.09 Million
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $1.52 Million - $1.93 Million	-22,492 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $1.46 Million - $2.11 Million	22,492 New	22,492 $1.66 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.59B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.